Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 10,795Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 10Tagrisso

PharmaCompass

01

Brand Name : Tagrisso

Osimertinib

arrow
Discovery Europe
Not Confirmed

Brand Name : Tagrisso

arrow
Discovery Europe
Not Confirmed

Osimertinib

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 4,328

2019 Revenue in Millions : 3,189

Growth (%) : 36

blank

02

Brand Name : Tagrisso

Osimertinib

arrow
Discovery Europe
Not Confirmed

Brand Name : Tagrisso

arrow
Discovery Europe
Not Confirmed

Osimertinib

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 5,015

2020 Revenue in Millions : 4,328

Growth (%) : 16

blank

03

Brand Name : Tagrisso

Osimertinib

arrow
Discovery Europe
Not Confirmed

04

Brand Name : Tagrisso

Osimertinib

arrow
Discovery Europe
Not Confirmed

05

Brand Name : Tagrisso

Osimertinib

arrow
Discovery Europe
Not Confirmed

Brand Name : Tagrisso

arrow
Discovery Europe
Not Confirmed

Osimertinib

Main Therapeutic Indication : Oncology

Currency : USD

2024 Revenue in Millions : 6,580

2023 Revenue in Millions : 5,799

Growth (%) : 13

blank

06

Brand Name : Tagrisso

Osimertinib Mesylate

arrow
Discovery Europe
Not Confirmed

07

Brand Name : Tagrisso

Osimertinib Mesylate

arrow
Discovery Europe
Not Confirmed

08

Brand Name : Tagrisso

Osimertinib Mesylate

arrow
Discovery Europe
Not Confirmed

09

Brand Name : Tagrisso

Osimertinib Mesylate

arrow
Discovery Europe
Not Confirmed

10

Brand Name : Tagrisso

Osimertinib

arrow
Discovery Europe
Not Confirmed

Brand Name : Tagrisso

arrow
Discovery Europe
Not Confirmed

Osimertinib

Main Therapeutic Indication : Oncology

Currency : USD

2019 Revenue in Millions : 3,189

2018 Revenue in Millions : 1,860

Growth (%) : 71

blank